The court grants AstraZeneca a preliminary injunction against Orion's generic version of Seroquel® Prolong
10 November 2015
With legal assistance from Plesner Law Firm, AstraZeneca AB and others have been successful in a Maritime and Commercial High Court case regarding Orion Corporation and Orion Pharma A/S' infringement of AstraZeneca's patent.
The Maritime and Commercial High Court has recently made a ruling in a case between AstraZeneca AB and others and Orion Corporation and Orion Pharma A/S regarding infringement of AstraZeneca AB's quetiapine sustained-release patent.
AstraZeneca AB was successful in all their claims in the Maritime and Commercial High Court case, and the court consequently injuncted Orion Pharma A/S' future sale of the Ketipinor product; a generic version of AstraZeneca's product Seroquel® Prolong.Peter-Ulrik Plesner, Attorney-at-Law and Partner, and Mette Hygum Clausen, Attorney-at-Law, assisted AstraZeneca AB and others in the case.